Dechra Pharmaceuticals PLC

Equities

DPH

GB0009633180

Delayed London S.E. 02:30:00 2024-01-16 am EST 5-day change 1st Jan Change
3,866 GBX -.--% Intraday chart for Dechra Pharmaceuticals PLC -.--% +0.21%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Stocks slump as Fed rate cut hope dwindles AN
Dechra Pharmaceuticals Delists From London Bourse Following Freya Bidco’s Takeover MT
EQT's Freya Bidco Completes Dechra Pharmaceuticals Purchase MT
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 100 Index CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE All-World Index CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 350 Index CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE All-Share Index CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from FTSE 350 (Ex Investment Companies) Index CI
Dechra Pharmaceuticals PLC(LSE:DPH) dropped from S&P Global BMI Index CI
EQT X EUR SCSp and EQT X USD SCSp managed by Eqt Fund Management S.à R.L. and Luxinva SA (the Offerors) completed the acquisition of Dechra Pharmaceuticals PLC. CI
Persimmon to replace outbound FTSE 100 constituent Dechra AN
EMEA Morning Briefing : Markets to Track Fresh Middle East Tensions DJ
EU clears Dechra Pharmaceuticals takeover by EQT funds AN
EQT's Dechra Takeover to Become Effective in Mid-January 2024 MT
EQT's Takeover of Dechra Pharmaceuticals Gets EU Antitrust Regulator's Nod MT
Inchcape to appoint Jerry Buhlmann to chair board of directors from May AN
EQT Secures Australian Nod for Dechra Pharmaceuticals Takeover MT
FTSE 100 Ends Down, Falling Behind European Peers DJ
Hargreaves Lansdown picks Dechra chair Alison Platt as chair AN
FTSE 100 falls; Halfords, Xaar plunge AN
Hargreaves Lansdown Names Dechra Pharmaceuticals Chair to Same Role MT
Hargreaves Lansdown says Dechra's Platt to be chair AN
UK's Hargreaves says Dechra's Platt to succeed Oppenheimer as chair RE
Dechra Pharmaceuticals director steps down after 12 years AN
Dechra Pharmaceuticals Plc Announces Directorate Change CI
Chart Dechra Pharmaceuticals PLC
More charts
Dechra Pharmaceuticals PLC specializes in the manufacturing and marketing of veterinary pharmaceutical products. Net sales break down by family of products as follows: - companion animal products (74.6%); - food producing animal products (11.5%); - equine health products (7.3%); - animal feeds (5.1%); - other (1.5%): products manufactured by third parties. Net sales are distributed geographically as follows: the United Kingdom (8.5%), Germany (9.2%), Europe (31.2%), the United States (37.9%) and other (13.2%).
Sector
-
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock
  2. Equities
  3. Stock Dechra Pharmaceuticals PLC - London S.E.
  4. News Dechra Pharmaceuticals PLC
  5. EQT Secures Australian Nod for Dechra Pharmaceuticals Takeover
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW